Home › Funds › Livelsberger Financial Advisory › ELV
Livelsberger Financial Advisory position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Livelsberger Financial Advisory reported holding 309 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$120K, representing 0.64% of its reported portfolio and ranking #35 among its reported holdings. Livelsberger Financial Advisory has disclosed ELV holdings in 4 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-10-31 · Source: SEC EDGAR Form 13F-HR
How Livelsberger Financial Advisory's ELV position evolved
Livelsberger Financial Advisory first disclosed a stake in ELV in Q4 2023 at 294 shares (US$139K). The position peaked in Q3 2024 at 297 shares, worth US$155K. Across 4 filings, Livelsberger Financial Advisory held the position steady without any share-count change. The most recent filing (Q3 2026) shows 309 shares valued at US$120K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 294 | $138.82K | New |
| Q3 2024 | 297 | $154.51K | New |
| Q2 2025 | 301 | $117.09K | New |
| Q3 2026 | 309 | $119.99K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on Livelsberger Financial Advisory
FAQ
How long has Livelsberger Financial Advisory held ELV?
Livelsberger Financial Advisory has disclosed ELV holdings in 4 of the last 12 reported quarters, going back to Q4 2023.
What is Livelsberger Financial Advisory's current position in ELV?
As of Q3 2026, Livelsberger Financial Advisory holds 309 shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $119.99K, representing 0.64% of its reported portfolio and ranking #35.
Has Livelsberger Financial Advisory been buying or selling ELV?
In the latest 13F filing (Q3 2026), Livelsberger Financial Advisory newly opened its position in ELV. The position peaked in Q3 2024 at 297 shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.